| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/26/2006 | US20060240548 Materials for constructing cell-chips, cell-chip covers, cell-chips coats, processed cell-chips and uses thereof |
| 10/26/2006 | US20060240547 Linear and membrane-like biodevices and bioreactors |
| 10/26/2006 | US20060240537 Isolated nucleic acid sequence encoding plant acid phosphatase |
| 10/26/2006 | US20060240532 Amplification, translation, transcription |
| 10/26/2006 | US20060240528 Polyketides and their synthesis |
| 10/26/2006 | US20060240525 Factor VII or VIIa - Like Molecules |
| 10/26/2006 | US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 10/26/2006 | US20060240521 DNA sequences for regulating transcription |
| 10/26/2006 | US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity |
| 10/26/2006 | US20060240519 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 10/26/2006 | US20060240517 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240513 Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom |
| 10/26/2006 | US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 10/26/2006 | US20060240465 CNG2B: a novel human cyclic nucleotide-gated ion channel |
| 10/26/2006 | US20060240432 Transmembrane serine protease probes for use as evaluative tool in detection of nervous system stem cells and treatment of neurodegenerative diseases; regenerative medicine; tissue engineering |
| 10/26/2006 | US20060240404 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 10/26/2006 | US20060240061 Tissue engineered blood vessels |
| 10/26/2006 | US20060240058 Combinatorial surface chip compositions for selection, differentiation and propagation of cells |
| 10/26/2006 | US20060240038 Cells used as carriers for bacteria |
| 10/26/2006 | US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
| 10/26/2006 | US20060240027 Conjugated with toxins, enzymes, radioactive compounds, and hematogenous cells; use in staging and diagnosis; treatment of metastasis |
| 10/26/2006 | US20060240024 T cell regulation |
| 10/26/2006 | US20060240020 Inhibition of complement activation |
| 10/26/2006 | US20060240012 For treating inflammation and immunopathy; rheumatoid arthritis |
| 10/26/2006 | US20060240005 Methods and compositions for increasing the efficiency of therapeutic antibodies using alloreactive natural killer cells |
| 10/26/2006 | US20060240003 Humanised antibodies to the epidermal growth factor receptor |
| 10/26/2006 | US20060239998 Prevention, treatment or reduction of bleeding disorders of hemophilia patients with inhibitory antibody against the C2 domain of Factor VIII; antihemophilic factor inhibitors; monoclonal cell lines expressing such anti-idiotypic antibodies; monoclonal cell lines expressing such anti-idiotypic antibodies |
| 10/26/2006 | US20060239988 Neuronal regeneration and compound administration methods |
| 10/26/2006 | US20060239985 Method of preparing cell for transplantation |
| 10/26/2006 | US20060239984 Promoter to il-18bp, its preparation and use |
| 10/26/2006 | US20060239983 Repairing damaged myocardium and/or myocardial cells utilizing differentiated cardiac stem cells; tissue engineering |
| 10/26/2006 | US20060239981 Bioreactor System and Method of Enhancing Functionality of Muscle Cultured In Vitro |
| 10/26/2006 | US20060239980 Cartilage-derived stem cells and applications thereof |
| 10/26/2006 | US20060239979 Dendritic cell presenting a-glycosylceramide derivative and antigent and usable in suppressing immune response |
| 10/26/2006 | US20060239978 Cellular expression of 65B13 in the neurons can be used as an index to select cells that are suitable in terms of their safety, survival rate, and network formation ability, for transplant therapy of neurodegenerative diseases such as Parkinson's disease |
| 10/26/2006 | US20060239974 Enhancing cell migration by increasing telomerase activity |
| 10/26/2006 | US20060239969 Isolated nucleic acid molecule; enhancing immunity to the protein product expressed by the HER2/neu tumor-associated antigen |
| 10/26/2006 | US20060239962 Rapid one-step generation of antigen loaded dendritic cell vaccine from precursors |
| 10/26/2006 | US20060239910 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 10/26/2006 | DE112004001708T5 Verfahren zur Herstellung einer nützlichen Zwischenstufe in der Alkaloid-Biosynthese unter Verwendung von RNAi-Technik A process for preparing a useful intermediate in the alkaloid biosynthesis using RNAi technology |
| 10/26/2006 | DE102005017000A1 Verfahren zur Herstellung eines Gewebetransplantatkonstruktes zur Rekonstruktion eines menschlichen oder tierischen Organs A method for producing a tissue transplant construct for reconstructing a human or animal body |
| 10/26/2006 | CA2648506A1 Cytotrophoblast stem cell |
| 10/26/2006 | CA2605631A1 Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms |
| 10/26/2006 | CA2605038A1 Mammalian expression systems |
| 10/26/2006 | CA2604925A1 Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors |
| 10/26/2006 | CA2604837A1 Choroid plexus preparation and uses thereof |
| 10/26/2006 | CA2604732A1 Vaccine against pandemic strains of influenza viruses |
| 10/26/2006 | CA2604515A1 Toll-like receptor 14 (tlr14 ) and use thereof |
| 10/26/2006 | CA2600986A1 Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene |
| 10/26/2006 | CA2574572A1 Modulation of cytokine signaling regulators and applications for immunotherapy |
| 10/25/2006 | EP1715053A1 Gene trap cassettes for random and targeted conditional gene inactivation |
| 10/25/2006 | EP1715051A1 Gene construct systems for isolating a pure population of cells of a single cell type |
| 10/25/2006 | EP1715050A1 Paraquat resistance gene and a vascular tissue- and trichome-specific promoter |
| 10/25/2006 | EP1715045A2 Recombinant antibodies for human therapy |
| 10/25/2006 | EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 10/25/2006 | EP1715034A1 Regulatory cell controlling immunological activity of t cell |
| 10/25/2006 | EP1715033A1 Medium for preparing feeder cells for embryonic stem cells and feeder cells |
| 10/25/2006 | EP1714980A1 Human receptor proteins, related reagents and methods |
| 10/25/2006 | EP1714971A2 Directed switch-mediated DNA recombination |
| 10/25/2006 | EP1714152A2 Monoclonal antibody based biomarker discovery and development platform |
| 10/25/2006 | EP1713903A2 Isolation, expansion and use of clonogenic endothelial progenitor cells |
| 10/25/2006 | EP1313360B1 An improved process for cultivation of algae |
| 10/25/2006 | EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses |
| 10/25/2006 | EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
| 10/25/2006 | EP1107993B1 Human monoclonal antibodies directed against the islet cell antigen ia-2 |
| 10/25/2006 | EP1097167B1 Neurotrophic growth factor |
| 10/25/2006 | EP1016866B1 Novel compound 2-amino-3-[2-(alpha-mannopyranosyl) indol-3-yl] propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound |
| 10/25/2006 | EP1012286B1 Allelic variant of human stat3 |
| 10/25/2006 | EP0977876B1 Nucleic acid molecules from artichoke (cynara scolymus) encoding enzymes having fructosyl polymerase activity |
| 10/25/2006 | EP0929662B1 Cell culture media for mammalian cells |
| 10/25/2006 | EP0901522B1 Immortal avian cells |
| 10/25/2006 | CN2830410Y Tissue engineering ambient nerve graft |
| 10/25/2006 | CN2830409Y Tissue engineering ambient nerve graft |
| 10/25/2006 | CN1852985A Process for the production of fine chemicals |
| 10/25/2006 | CN1852982A Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 10/25/2006 | CN1852981A The anti-platelet membrane glycoprotein VI monoclonal antibody |
| 10/25/2006 | CN1852974A Compositions and methods for treating and diagnosing cancer |
| 10/25/2006 | CN1852973A Method for the isolation and expansion of cardiac stem cells from biopsy |
| 10/25/2006 | CN1852972A Composition for coating support for preparation of cell sheet, support for preparation of cell sheet and process for producing cell sheet |
| 10/25/2006 | CN1852971A Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 10/25/2006 | CN1852922A Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations |
| 10/25/2006 | CN1852741A Compounds and methods for downregulating the effects of TGF-beta |
| 10/25/2006 | CN1852736A Immunoglobulin chimeric monomer-dimer hybrids |
| 10/25/2006 | CN1852734A Consensus/ancestral immunogens |
| 10/25/2006 | CN1850971A Method for sorting human marrow mesenchymal stemcell by monoclonal antibody ZUF10 immunomagnetic bead |
| 10/25/2006 | CN1850970A Method for sorting primary human marrow mesenchy malstem cell by monoclonal antibody ZUB4 immunomagnetic bead |
| 10/25/2006 | CN1850969A Method for sorting primary human marrow mesenchymal steam cell by monoclonal antibody ZUC3 immunomagnetic bead |
| 10/25/2006 | CN1850968A Method for sorting human marrow mesenchymal stem cell by monoclonal antibody ZUE12 immunomagnetic bead |
| 10/25/2006 | CN1850967A Method for preparing bioreactor for in vitro biological artificial liver |
| 10/25/2006 | CN1850966A Immunomagnetic nano particle cell separator, and its preparing method and use |
| 10/25/2006 | CN1850272A Medicine for treating alopecia areata and its clinical use |
| 10/25/2006 | CN1281747C i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene |
| 10/25/2006 | CN1281745C Tissue engineered peripheral nerve graft |
| 10/25/2006 | CN1281740C Biological differentiation revellent, its preparation process and application differenting inducing in from stem cells to cardiacy muscular tissue cells |
| 10/25/2006 | CN1281739C Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood and differentation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into |
| 10/25/2006 | CN1281625C WT1 modified peptide |
| 10/25/2006 | CA2511457A1 Linear and membrane-like biodevices and bioreactors |
| 10/24/2006 | US7127379 Method for the evolutionary design of biochemical reaction networks |
| 10/24/2006 | US7126044 Plant genes conferring resistance to Citrus tristeza virus |